What A Recession Is Like For Early Retirees: The Good And Bad

If we're not already in a recession, we may soon enter one due to aggressive trade policies that are fueling tremendous uncertainty. As companies and consumers pull back on spending, millions of jobs could be lost, trillions in stock market

Dario Meyer 21 Min Read

Using Lumber for Uses Other Than Construction Projects

Coming from nature, lumber is a phenomenal material that can be used for a variety of tasks and purposes. One major usage is making different sorts of construction projects. (Construction takeoff services help in understanding the overall material requirements for

Sam Hubbert 5 Min Read

Your Amgen Benefits & Career: Financial Planning for Employees and Executives

To make Wealthtender free for readers, we earn money from advertisers, including financial professionals and firms that pay to be featured. This creates a conflict of interest when we favor their promotion over others. Read our editorial policy and terms

Pat Crawley 23 Min Read

Hot Games

Aspect

$1.99

Sportlight

- Advertisement -
Ad image
- Advertisement -
Ad image

Categories

More News

5 Key Steps to Prepare for Retirement

To make Wealthtender free for readers, we earn money from advertisers, including

Pat Crawley Pat Crawley

The Early Retiree’s Guide to Funding Retirement Accounts

When it comes to saving for retirement, knowing which account to fund

Dario Meyer Dario Meyer

How to File Your Income Taxes for Free (or at discount)

I remember the first time I filed my taxes. I was dropping

Kayne Collins Kayne Collins

The Voice of a Generation: How Mohsen Fallahian Is Shaping the Future of Emirati Literature

In a region witnessing a literary awakening, one name continues to echo

Sam Hubbert Sam Hubbert

Should You Trust Financial “Expert” Market Forecasts?

Insights By  Opher Ganel, Ph.D. Opher Ganel is an accomplished scientist (particle

Pat Crawley Pat Crawley

Pharma’s Execution Gap: Solved Through Systems, Not Spend

When a pharmaceutical company receives FDA approval for a new therapy, it

Sam Hubbert Sam Hubbert